AMF Tjänstepension’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,479
Closed -$5.89M 119
2025
Q4
$5.89M Hold
33,479
0.04% 94
2025
Q3
$4.69M Sell
33,479
-25,636
-43% -$3.47M 0.03% 117
2025
Q2
$7.42M Hold
59,115
0.05% 131
2025
Q1
$8.09M Hold
59,115
0.06% 171
2024
Q4
$9.04M Sell
59,115
-4,818
-8% -$813K 0.06% 163
2024
Q3
$12.4M Hold
63,933
0.09% 154
2024
Q2
$14.8M Buy
+63,933
New +$13.9M 0.11% 120
2024
Q1
Sell
-43,849
Closed -$11.3M 26
2023
Q4
$11.3M Hold
43,849
0.1% 144
2023
Q3
$11.3M Hold
43,849
0.11% 126
2023
Q2
$12.5M Sell
43,849
-1,796
-4% -$535K 0.12% 130
2023
Q1
$12.7M Hold
45,645
0.13% 117
2022
Q4
$12.6M Hold
45,645
0.14% 121
2022
Q3
$12.2M Sell
45,645
-24,854
-35% -$5.28M 0.14% 114
2022
Q2
$14.4M Sell
70,499
-33,134
-32% -$6.77M 0.14% 111
2022
Q1
$21.8M Sell
103,633
-859
-0.8% -$187K 0.16% 117
2021
Q4
$25.1M Buy
104,492
+9,209
+10% +$2.37M 0.17% 112
2021
Q3
$27M Buy
95,283
+13,131
+16% +$4.3M 0.2% 110
2021
Q2
$28.4M Sell
82,152
-18,612
-18% -$5.64M 0.2% 112
2021
Q1
$28.2M Hold
100,764
0.21% 101
2020
Q4
$24.7M Buy
100,764
+18,682
+23% +$4.82M 0.2% 105
2020
Q3
$23.3M Sell
82,082
-320
-0.4% -$89.3K 0.21% 103
2020
Q2
$22M Buy
82,402
+7,936
+11% +$2.39M 0.23% 101
2020
Q1
$23.6M Sell
74,466
-54,495
-42% -$16.5M 0.3% 76
2019
Q4
$38.3M Sell
128,961
-12,846
-9% -$3.56M 0.37% 69
2019
Q3
$33M Buy
141,807
+15,988
+13% +$3.72M 0.34% 84
2019
Q2
$29.4M Buy
125,819
+27,879
+28% +$6.44M 0.29% 104
2019
Q1
$23.2M Sell
97,940
-74,344
-43% -$23.4M 0.23% 122
2018
Q4
$51.8M Sell
172,284
-22,880
-12% -$7.3M 0.57% 49
2018
Q3
$69M Sell
195,164
-23,655
-11% -$8.14M 0.63% 51
2018
Q2
$63.5M Sell
218,819
-15,736
-7% -$4.42M 0.61% 51
2018
Q1
$64.2M Sell
234,555
-9,129
-4% -$2.83M 0.67% 52
2017
Q4
$77.6M Buy
243,684
+11,623
+5% +$3.73M 0.76% 45
2017
Q3
$72.7M Buy
232,061
+20,310
+10% +$6.01M 0.8% 39
2017
Q2
$57.9M Hold
211,751
0.66% 52
2017
Q1
$57.9M Sell
211,751
-3,488
-2% -$986K 0.66% 52
2016
Q4
$61M Sell
215,239
-56,145
-21% -$16.6M 0.71% 45
2016
Q3
$85M Sell
271,384
-10,574
-4% -$3.13M 1.07% 21
2016
Q2
$68.2M Sell
281,958
-3,000
-1% -$791K 0.88% 37
2016
Q1
$74.2M Buy
284,958
+17,134
+6% +$4.53M 0.97% 30
2015
Q4
$82M Buy
267,824
+60,935
+29% +$17.5M 1.15% 22
2015
Q3
$60.4M Buy
206,889
+100
+0% +$33K 0.91% 31
2015
Q2
$83.5M Sell
206,789
-24,933
-11% -$10M 1.16% 20
2015
Q1
$97.8M Sell
231,722
-1,091
-0.5% -$430K 1.23% 19
2014
Q4
$79M Buy
+232,813
New +$75.3M 1% 29

Other funds holding BIIB

AMF Tjänstepension's BIIB Position: Q1 2026 in Review

AMF Tjänstepension sold out of Biogen (BIIB) in Q1 2026, closing a stake of 33,479 shares — an estimated $5.89M sold.

AMF Tjänstepension first reported a position in BIIB in Q4 2014 and held it in 44 quarters. The position peaked at $97.8M in Q1 2015. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • AMF Tjänstepension reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • AMF Tjänstepension sold 33,479 Biogen shares in Q1 2026, an estimated $5.89M.
  • AMF Tjänstepension first reported a position in Biogen in Q4 2014 and held it in 44 quarters.
  • AMF Tjänstepension's Biogen position peaked at $97.8M in Q1 2015.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on AMF Tjänstepension's 13F filing for Q1 2026, filed 4 May 2026.